Larvol Delta - Moleculin-Announces-Agreement-to-Produce-WP1122-for-Expanded-Development-of-Potential-COVID19-and-Oncology-Drug-Candidate

WP1122 - Moleculin, CNS Pharma, WPD Pharma

https://www.prnewswire.com/news-releases/moleculin-announces-agreement-to-produce-wp1122-for-expanded-development-of-potential-covid-19-and-oncology-drug-candidate-301093667.html

Jul 15, 2020

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next